Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02880384 · ClinicalTrials.gov registry record · NA
Pathogen Detection and Community Acquired Pneumonia
A NA study, sponsored by Providence Health & Services.
- Completed
- Registry status
- NA
- Development phase
- 570
- Enrollment target
NCT02880384: Completed NA study, sponsored by Providence Health & Services.
NCT02880384 is a NA study that has completed, run by Providence Health & Services. The registered enrollment target is 570 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02880384, a NA study, has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 570 participants
- Enrollment target
Study Summary
Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using current diagnostic tests to the number detected using the BioFire Diagnostics investigational polymerase chain reaction (PCR) platform.
Primary Outcome
Compare the number of CAP pathogens detected using current diagnostic bundle to the number detected using the FilmArray LRTI v.2.0 IUO Panel.
Interventions
- OTHER FilmArray LRTI v.2.0 IUO Panel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 570 participants |
| Start Date | 2017-01 |
| Est. Completion | 2020-12-20 |
| Phase | NA |
What the finished NCT02880384 record still lists
NCT02880384 is an interventional study that assigns participants to a tested intervention. The registered 570 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (59% lower).
The record links to 0 conditions, and to 1 intervention - of which FilmArray LRTI v.2.0 IUO Panel is the first listed.
NCT02880384 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02880384 about?
NCT02880384 is a clinical study titled "Pathogen Detection and Community Acquired Pneumonia". Study to compare the number of community-acquired pneumonia (CAP) pathogens detected using current diagnostic tests to the number detected using the BioFire Diagnostics investigational polymerase chain reaction (PCR) platform.
What is the current status of trial NCT02880384?
This trial is currently completed. It is a NA study. The enrollment target is 570 participants. The study started on 2017-01. Estimated completion is 2020-12-20.
What interventions are being tested in trial NCT02880384?
The interventions under investigation include: FilmArray LRTI v.2.0 IUO Panel (OTHER).
Who is sponsoring clinical trial NCT02880384?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02880384's enrollment target sits among peer trials
570 180th of 2000 higher than 1,821 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
- NCT07266831 · 570 participants · Phase 2
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia